HER2 Low Breast Adenocarcinoma
1 clinical trials · Condition
◉ Watch HER2 Low Breast Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| TRUDI: TDXD+Durva in HER2+/Low IBC (NCT05795101) | Filipa Lynce, MD | 2023-05-04 |
Track HER2 Low Breast Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.